Astal Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 09/10/2025 inter alia to consider and approve 1) To increase authorised share capital of the Company in accordance with Companies Act 2013 and subject to any regulatory/ statutory approvals as may be required and the approval of the shareholders of the Company; 2) To consider and if thought fit approve the issuance of equity shares / convertible warrants of the Company on a preferential basis in accordance with the Companies Act 2013 read with the rules notified thereunder each as amended and the Securities and Exchange Board of India (Issue of Capital and Disclosure Requirements) Regulations 2018 as amended and such other acts rules and regulations as may be applicable subject to any regulatory/ statutory approvals as may be required and the approval of the shareholders of the Company; and other items.

Avasara Finance Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 09/10/2025 inter alia to consider and approve the Un-Audited Financial Results of the company for the Quarter and Half year ended September 30 2025 and to appoint Mr. Eugene Oommen Koshy (DIN: 02357608) as an Additional Non- Executive Director. In view of the above the Trading Window for dealing in the securities of the Company that was closed for all the Designated Persons from October 01 2025 will continue to remain closed and shall reopen only after 48 hours of the declaration of Un-Audited Financial Results to the Stock Exchanges. Avasara Finance Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 09/10/2025 ,inter alia, to consider and approve the Un-Audited Financial Results of the company for the Quarter and Half year ended September 30, 2025 and to appoint Mr. Eugene Oommen Koshy (DIN: 02357608) as an Additional Non- Executive Director. In view of the above, the Trading Window for dealing in the securities of the Company that was closed for all the Designated Persons from October 01, 2025 will continue to remain closed and shall reopen only after 48 hours of the declaration of Un-Audited Financial Results to the Stock Exchanges. (As Per BSE Announcement Dated On : 06.10.2025)

GM Breweries Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 09/10/2025 inter alia to consider and approve Notice For Board Meeting to be held on 09-10-2025 for Un-Audited Quarterly Financials Results for the Quarter ended 30-09-2025

Inter alia, to: 1. Consider and approve various fund-raising options for the Company, as the Board may deem appropriate. 2. Consider and approve any other matter incidental and connected thereto.

Tata Elxsi Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 09/10/2025 inter alia to consider and approve the Audited Financial Results for the quarter and half-year ended September 30 2025